1-4 of 4
nephrology
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Trends in ADAMTS13 Activity Testing over the Last 7 Years in a Single UK TTP Specialist Centre

Kat Moss, MBBS, MRCP, Colin Downey, Ashley Lawrenson, Tina Dutt, PhD MBBS, BSc, FRCPath, FRCP, Rebecca J Shaw
Journal: Blood
Blood (2018) 132 (Supplement 1): 3526.
https://doi.org/10.1182/blood-2018-99-119331
Published: 2018
Journal Articles

Treatment of Myeloma Cast Nephropathy (MCN): A Randomized Trial Comparing Intensive Haemodialysis (HD) with High Cut-Off (HCO) or Standard High-Flux Dialyzer in Patients Receiving a Bortezomib-Based Regimen (the MYRE Study, by the Intergroupe Francophone du Myélome (IFM) and the French Society of Nephrology (SFNDT))

Frank Bridoux, MD PhD, Brigitte Pegourie, MD, Karine Augeul-Meunier, MD, Bruno Royer, MD, Bertrand Joly, MD, Thierry Lamy, MD PhD, Brigitte Kolb, Lofti Benboubker, Bertrand Arnulf, MD, Arnaud Jaccard, MD PhD, Sylvie Chevret, Jean-Paul Fermand, MD
Journal: Blood
Blood (2016) 128 (22): 978.
https://doi.org/10.1182/blood.V128.22.978.978
Published: 2016
Journal Articles

Case Mix of Nonmalignant Hematology in Inpatient Hematology/Oncology Consultation: Review of a 14 Month Experience from a Single University/Community Hybrid Hospital

Robert T Means, MD
Journal: Blood
Blood (2014) 124 (21): 5974.
https://doi.org/10.1182/blood.V124.21.5974.5974
Published: 2014
Journal Articles

Evaluating Mortality with Erythropoietic Stimulating Agents (ESAs) in the Nephrology Setting: The Distinction between Evaluating Trials That Measure Survival as a Primary or Secondary Efficacy Endpoint Versus a Safety Endpoint.

Sara E. Barnato, MD, Charles L. Bennett, MD PhD MPP, Kathleen Elverman, Dennis P. West, PhD, Mark Courtney, MD
Journal: Blood
Blood (2007) 110 (11): 962.
https://doi.org/10.1182/blood.V110.11.962.962
Published: 2007